Matthew C. Abramowitz

Matthew C. Abramowitz

Radiation Oncology

1192 East Newport Center Drive
Suite 100
Deerfield Beach, FL 33442

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST).

Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST).

Journal: BJU international

Published: February 27, 2026

Metabolomic Insights Into Saliva as a Non-Invasive Surrogate for Serum to Enable Community-Based Biomarker Investigation.

Metabolomic Insights Into Saliva as a Non-Invasive Surrogate for Serum to Enable Community-Based Biomarker Investigation.

Journal: The Prostate

Published: December 06, 2025

MRI-based patient selection for active surveillance in prostate cancer using U-Found: a generalized deep learning model.

MRI-based patient selection for active surveillance in prostate cancer using U-Found: a generalized deep learning model.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: October 21, 2025

Assessment of Online Adaptive MRI-Guided Stereotactic Body Radiotherapy (SBRT) With an Integrated Boost to the Dominant Lesion in Prostate Cancer.

Assessment of Online Adaptive MRI-Guided Stereotactic Body Radiotherapy (SBRT) With an Integrated Boost to the Dominant Lesion in Prostate Cancer.

Journal: Cureus

Published: October 07, 2025

Integration of Habitat Risk Score in Radiation Therapy for Prostate Cancer.

Integration of Habitat Risk Score in Radiation Therapy for Prostate Cancer.

Journal: International journal of radiation oncology, biology, physics

Published: May 22, 2025

Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial.

Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 07, 2025

Correlation of T2-Weighted Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Cone Beam Computed Tomography (CBCT) Radiomic Features for Prostate Cancer.

Correlation of T2-Weighted Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Cone Beam Computed Tomography (CBCT) Radiomic Features for Prostate Cancer.

Journal: Cureus

Published: February 20, 2025

Defining occult disease in glioblastoma using spectroscopic MRI: implications for clinical target volume delineation.

Defining occult disease in glioblastoma using spectroscopic MRI: implications for clinical target volume delineation.

Journal: Radiation oncology (London, England)

Published: December 03, 2024

Patterns of Recurrence Following Radiation and ADT for Pathologic Lymph Node-Positive Prostate Cancer: A Multi-institutional Study.

Patterns of Recurrence Following Radiation and ADT for Pathologic Lymph Node-Positive Prostate Cancer: A Multi-institutional Study.

Journal: Practical radiation oncology

Published: October 07, 2024

HRS Improves Active Surveillance for Prostate Cancer by Timely Identification of Progression.

HRS Improves Active Surveillance for Prostate Cancer by Timely Identification of Progression.

Journal: Academic radiology

Published: August 05, 2024

Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS score.

Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS score.

Journal: Prostate cancer and prostatic diseases

Published: May 28, 2024

Integrated framework for quantitative T2-weighted MRI analysis following prostate cancer radiotherapy.

Integrated framework for quantitative T2-weighted MRI analysis following prostate cancer radiotherapy.

Journal: Physics and imaging in radiation oncology

Published: May 22, 2024

Showing 1-12 of 65

Last Updated: 09/26/2026